The Effect of Combination Therapy Using Li-ESWT and PDE-5 Inhibitor in Patients With Erectile Dysfunction
NCT ID: NCT05043896
Last Updated: 2021-09-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2019-12-10
2020-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Low-Intensity Extracorporeal Shock Wave Treatment for Erectile Dysfunction: A Randomized, Controlled, Double Blind Trial
NCT03006536
The Effect of Low Intensity Shock Wave Therapy for ED in PDE5i Non Responders
NCT01272297
Efficacy and Safety of Focused Shockwave Therapy Plus Tadalafil vs Tadalafil Alone in Patient With Erectile Dysfunction
NCT05823506
Comparative Effectiveness and Safety of Three Protocols Usin Li-ESWT for Erectile Dysfunction
NCT03308409
Treatment of Erectile Dysfunction With Low-intensity Extracorporeal Shockwave Therapy
NCT03986359
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Parameters used for comparation are EHS score, IIEF-5 score, VEGF level and PSV
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Combination therapy
Li-ESWT + tadalafil
Li-ESWT
Li-ESWT twice weekly for 4 weeks
Tadalafil 2.5Mg Tab
tadalafil 2.5mg once daily
Single Therapy
tadalafil only
Tadalafil 2.5Mg Tab
tadalafil 2.5mg once daily
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Li-ESWT
Li-ESWT twice weekly for 4 weeks
Tadalafil 2.5Mg Tab
tadalafil 2.5mg once daily
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Married
* Sexually active
* Consenting to participate in the trial
Exclusion Criteria
* Spinal injury
* History of malignancy
* Penile anatomy abnormalities
* Allergic and Contraindications to tadalafil
* On anti-mitotic drugs
40 Years
55 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dr. Soetomo General Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Andrian, dr., Sp.And
Resident of Andrology Department, Principal Investigator, Medical Doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tjahjo Tanojo, dr
Role: PRINCIPAL_INVESTIGATOR
Dr. Soetomo General Hospital, Andrology Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
dr. Soetomo General Hospital
Surabaya, East Java, Indonesia
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol: Study Protocol Chart
Document Type: Study Protocol: Ethical Clearance
Document Type: Study Protocol and Statistical Analysis Plan: Study Protocols and Statistical Analysis Plan
Document Type: Statistical Analysis Plan: Statistics Results
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1690/KEPK/XII/2019
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.